Regenxbio to Develop Antibody-based Gene Therapy for Hereditary Angioedema
News
Regenxbio is exploring a new hereditary angioedema (HAE) treatment that harnesses viral vectors to deliver an antibody-based gene therapy, the company announced. The treatment will deliver the genetic sequence ... Read more